Opportunity

SAM #75F40126Q134239

FDA Solicitation for Subcutaneous Injection Site Simulator System and Support

Buyer

FDA Office of the Associate General Counsel for Administrative Law

Posted

July 23, 2026

Respond By

July 31, 2026

Identifier

75F40126Q134239

NAICS

334516

The U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Review (CDER), Division of Pharmaceutical Quality Research V (DPQRV) is seeking to procure a specialized laboratory system: - Buyer: FDA, CDER, DPQRV - Product requested: One in vitro Subcutaneous Injection Site Simulator (SCISSOR) system - System must include: - Multiple independent chambers (minimum six) - Integrated optical detection systems - Automated sampling and injection - Fraction collection - Comprehensive software control - Compatibility with FDA's existing spectrophotometer system - Intended use: Regulatory research for complex long-acting injectable drug products and bioequivalence studies - Services required: - Complete installation (hardware, software, integration) - On-site and remote training for FDA personnel - Technical support during business hours, including remote diagnostics and software updates during warranty - Warranty: Minimum one-year manufacturer warranty from system acceptance - Notable requirements: - System must be delivered as a complete, integrated solution - Training and documentation must be comprehensive - Firm fixed-price contract; small business set-aside under NAICS 334516 - No specific OEMs or part numbers are named in the solicitation - All technical requirements are detailed in the solicitation attachment

Description

FDA's Division of Pharmaceutical Quality Research V (DPQRV) requires a subcutaneous injection site simulator (SCISSOR).  Please see the attached PDF file titled FDA 75F40126Q134239

View original listing